Crinetics Pharmaceuticals CRNX Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Crinetics Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Crinetics Pharmaceuticals's quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Crinetics Pharmaceuticals's quick ratio?
- Crinetics Pharmaceuticals (CRNX) reported quick ratio of 18.6× in Q1 2026.
- How has Crinetics Pharmaceuticals's quick ratio changed year-over-year?
- Crinetics Pharmaceuticals's quick ratio decreased by 17.6% year-over-year, from 22.5× to 18.6×.
- What is the long-term trend for Crinetics Pharmaceuticals's quick ratio?
- Over 5 years (2020 to 2025), Crinetics Pharmaceuticals's quick ratio has grown at a -6.2% compound annual growth rate (CAGR), from 16.9× to 12.3×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.